PRMA Consulting becomes Avalere Health, creating the connections that make better health happen

We are delighted to share some exciting news with you. On October 18, 2023, Fishawack Health and member company PRMA Consulting rebranded as a single unified company: Avalere Health.

By rebranding, we have united our 1,500+ team members under shared purpose, culture, values, and infrastructure. We have invested in our people and platforms to provide a common way of partnering with colleagues and clients, giving you easier access to the breadth of our preclinical to post-launch commercialization solutions.

Together, we powerfully and purposefully connect science and creativity, technology and data, ability, and agility, partnering with you to uncover the human relevance in complex data and science.

The rebrand and integration do not signal any change to your account team, the ownership, or the management of the company. 

Webinars

Driving BioPharma Access in Europe: Insights ...

Read more >

EBOOK

Value, Evidence, and Access: insights for ...

Read more >

EBOOK

Digital therapeutics: policy, access, value, and ...

Read more >

Blog

Evidence generation and launch strategies in ...

Read more >

Articles

Value, Evidence, and Access: insights for ...

Read more >

Blog

Digital therapeutics: value, evidence, and access ...

Read more >

EBOOK

Precision medicine: positioning for market access ...

Read more >

Blog

Welcoming Philip Drew, Head of Global ...

Read more >

Blog

Evidence supporting reimbursement of digital therapeutics

Read more >

Blog

Reducing the care gap in cancer ...

Read more >

Blog

ISPOR 2023: insight from Avalere’s expert ...

Read more >

Webinars

Positioning for market access success in ...

Read more >

Blog

AMCP 2023: key trends and highlights

Read more >

Blog

Why a market access career in ...

Read more >

Blog

E-learning for market access professionals

Read more >

Blog

Showcasing Robust Policy, Access, Value, and ...

Read more >

Blog

Principles of HTA Early Scientific Advice ...

Read more >

Blog

Driving BioPharma value, evidence, and access ...

Read more >

Articles

Market access success in the evolving ...

Read more >

Blog

5 benefits of e-learning for your market ...

Read more >

Articles

Cell and gene therapy: navigating the ...

Read more >

Blog

Market access careers in the Asia-Pacific ...

Read more >

Blog

Driving BioPharma value, evidence, and access ...

Read more >

Blog

The benefits of utilizing Early Scientific ...

Read more >

Blog

Driving BioPharma value, evidence, and access ...

Read more >

Blog

Cell and gene therapies: common challenges ...

Read more >

Blog

Avalere’s Healthcare Industry Outlook Report 2023

Read more >

Blog

Driving BioPharma value, evidence, and access ...

Read more >